Summary of the risk management plan for Deferipron Orifarm

Share "Summary of the risk management plan for Deferipron Orifarm"

N/A

Protected

Ano acadêmico: 2023

Info

Descarregar agora

Protected

Academic year: 2023

Share "Summary of the risk management plan for Deferipron Orifarm"

Copied!

Carregando.... (Ver texto completo agora)

Descarregar agora ( 3 páginas )

Texto

Referências

Descarregar agora ( PDF - 3 páginas - 92.94 KB )

Documentos relacionados

VI.2.2 Summary of treatment benefit 99m Tc-Pertechnetate is the most important diagnostic agent today

MONTEK Radionuclide generator Risk Management Plan 2014 29 / 69 MODULE 1 VI.2.4 Summary of safety concerns Important identified risks Risk What is known Preventability

Documentos relacionados

II.B Summary of Important Risks

Risk Management Plan

EU Risk Management Plan Lenalidomide

Summary of the risk management plan for lenalidomide

Lenalidomide Basics 2.5 mg, 5 mg, 7.5 mg 10 mg, 15 mg, 20 mg and 25 mg hard capsules

Summary of risk management plan for [Product name]

Summary of risk management plan for Bimatoprost Timolol Zentiva 0.3 mg / ml + 5 mg / ml, eye drops solution

RMP template 2.0.1 draft